Literature DB >> 8764508

Construction of CTB fusion proteins for screening of monoclonal antibodies against Salmonella typhi OmpC peptide loops.

J Paniagua-Solís1, J Sánchez, V Ortiz-Navarrete, C R González, A Isibasi.   

Abstract

Mice were immunized with resin-bound peptides whose sequences have been proposed to be part of exposed loops in Salmonella typhi outer membrane protein OmpC. To screen hybridomas for monoclonal antibodies against those epitopes, we designed fusion proteins where the candidate peptide sequence was attached to the amino end of cholera toxin B-subunit (CTB). The constructed fusion proteins allowed the efficient selection of positive clones by GM1-ELISA. Selected antibodies recognized purified OmpC and whole Salmonella bacteria. This suggests a native structure of our genetically attached peptides in agreement with immunological properties reported for previous CTB recombinant fusion proteins. In a more general context, CTB hybrids could be used to screen for antibodies towards immunogenic epitopes in other systems. This might turn out to be particularly useful when producing antibodies against peptide sequences in microorganisms whose handling is difficult or that pose inherent health risks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764508     DOI: 10.1111/j.1574-6968.1996.tb08359.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  A cloning vector for efficient generation of cholera toxin B gene fusions for epitope screening.

Authors:  I Secundino; J Paniagua-Solís; A Isibasi; J Sanchez
Journal:  Mol Biotechnol       Date:  1999-02       Impact factor: 2.695

2.  Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides.

Authors:  K M Williams; E C Bigley; R B Raybourne
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Conservation of the OmpC Porin Among Typhoidal and Non-Typhoidal Salmonella Serovars.

Authors:  Nuriban Valero-Pacheco; Joshua Blight; Gustavo Aldapa-Vega; Phillip Kemlo; Marisol Pérez-Toledo; Isabel Wong-Baeza; Ayako Kurioka; Christian Perez-Shibayama; Cristina Gil-Cruz; Luvia E Sánchez-Torres; Rodolfo Pastelin-Palacios; Armando Isibasi; Arturo Reyes-Sandoval; Paul Klenerman; Constantino López-Macías
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.